-
Publication Venue For
-
Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma..
13:1165.
2022
-
Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma..
13:576-582.
2022
-
P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses.
12:2252-2265.
2021
-
Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study..
12:1230-1242.
2021
-
Unexpected zinc dependency of ferroptosis - What is in a name?.
12:1126-1127.
2021
-
Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors..
12:1-3.
2021
-
Diffusion-weighted MR imaging histogram analysis in HIV positive and negative patients with primary central nervous system lymphoma as a predictor of outcome and tumor proliferation..
11:4093-4103.
2020
-
Ferroptosis of epithelial ovarian cancer: genetic determinants and therapeutic potential.
11:3562-3570.
2020
-
A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer.
11:3105-3117.
2020
-
Efficacy of osimertinib against EGFRvIII+ glioblastoma..
11:2074-2082.
2020
-
TAK1 regulates the tumor microenvironment through inflammatory, angiogenetic and apoptotic signaling cascades..
11:1961-1970.
2020
-
A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancer..
11:1334-1343.
2020
-
Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort..
11:758.
2020
-
Erratum: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort (Oncotarget (2019) 10 (4857-4867) DOI: 10.18632/oncotarget.27108).
11:758.
2020
-
Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation (Oncotarget (2019) 10 (1874-1886) DOI: 10.18632/oncotarget.26740).
10:6045-6046.
2019
-
Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma.
10:5671-5679.
2019
-
Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort..
10:4857-4867.
2019
-
Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma..
10:4546-4555.
2019
-
Integrating germline and somatic genomic analysis to probe etiological mechanism in malignant glioma..
10:3086-3087.
2019
-
ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation..
10:1874-1886.
2019
-
Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells..
10:1056-1069.
2019
-
UDP-α-D-glucose 6-dehydrogenase: A promising target for glioblastoma.
10:1542-1543.
2019
-
Intermediate phenotypes underlying osteosarcoma risk..
9:37345-37346.
2018
-
UBE2N plays a pivotal role in maintaining melanoma malignancy..
9:37347-37348.
2018
-
T-cell exhaustion in glioblastoma..
9:35287-35288.
2018
-
Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation..
9:33804-33817.
2018
-
Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1..
9:31214-31230.
2018
-
N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression..
9:31231-31243.
2018
-
Pre-diagnostic biomarkers of metabolic dysregulation and cancer mortality..
9:16099-16109.
2018
-
The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selection..
9:7844-7858.
2018
-
Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts..
9:3459-3482.
2018
-
An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphoma.
9:16213-16219.
2018
-
Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma.
9:346-360.
2018
-
Cell surface GRP78 promotes tumor cell histone acetylation through metabolic reprogramming: a mechanism which modulates the Warburg effect..
8:107947-107963.
2017
-
Differential response to exercise in claudin-low breast cancer..
8:100989-101004.
2017
-
CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease..
8:100421-100432.
2017
-
Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk..
8:94900-94909.
2017
-
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy..
8:96496-96505.
2017
-
The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cells..
8:91914-91927.
2017
-
Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides..
8:77567-77585.
2017
-
Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors..
8:76644-76655.
2017
-
Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival..
8:74595-74606.
2017
-
Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies..
8:73419-73432.
2017
-
Leptomeningeal disease: current diagnostic and therapeutic strategies..
8:73312-73328.
2017
-
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci..
8:64670-64684.
2017
-
ROS-independent Nrf2 activation in prostate cancer..
8:67506-67518.
2017
-
Racial differences in prostate inflammation: results from the REDUCE study..
8:71393-71399.
2017
-
Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors.
2017
-
ROS-independent Nrf2 activation in prostate cancer.
2017
-
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer..
8:41474-41486.
2017
-
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci.
2017
-
Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.
8:25848-25863.
2017
-
Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies..
8:25848-25863.
2017
-
Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations..
8:24362-24371.
2017
-
Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging..
8:24213-24223.
2017
-
MDM4 genetic variants and risk of gastric cancer in an Eastern Chinese population..
8:19547-19555.
2017
-
Is there a dose-dependent effect of genetic susceptibility loci for gastric cancer on prognosis of the patients?.
8:18435-18443.
2017
-
Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma..
8:17586-17592.
2017
-
A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors..
8:16690-16703.
2017
-
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity..
8:10425-10436.
2017
-
Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation.
8:3826-3839.
2017
-
Comparison between proton boron fusion therapy (PBFT) and boron neutron capture therapy (BNCT): A monte carlo study.
8:39774-39781.
2017
-
Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.
8:42438-42454.
2017
-
Does uneven geographic distribution of urologists effect bladder and prostate cancers mortality? National health insurance data in Korea from 2007-2011.
8:65292-65301.
2017
-
Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma.
8:32201-32211.
2017
-
Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients.
8:15912-15923.
2017
-
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy.
8:96496-96505.
2017
-
Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy.
8:104552-104559.
2017
-
New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate..
8:1007-1022.
2017
-
Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib.
8:87044-87053.
2017
-
The clinical significance of c-Kit mutations in metastatic oral mucosal melanoma in China.
8:82661-82673.
2017
-
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface..
7:84030-84042.
2016
-
Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia..
7:84214-84227.
2016
-
Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population..
7:82384-82395.
2016
-
Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma..
7:81281-81291.
2016
-
Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma..
7:80599-80611.
2016
-
Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models..
7:79828-79841.
2016
-
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors..
7:76565-76576.
2016
-
Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia..
7:72733-72745.
2016
-
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration..
7:72381-72394.
2016
-
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer..
7:69097-69110.
2016
-
Carcinogen 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis is accelerated in Smad3 heterozygous mice compared to Smad3 wild type mice..
7:64878-64885.
2016
-
Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood..
7:62898-62911.
2016
-
Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study..
7:61716-61727.
2016
-
Potential implications of Apolipoprotein E in early brain injury after experimental subarachnoid hemorrhage: Involvement in the modulation of blood-brain barrier integrity..
7:56030-56044.
2016
-
Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149..
7:55721-55731.
2016
-
Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer..
7:50507-50521.
2016
-
Associations between smoking behavior-related alleles and the risk of melanoma..
7:47366-47375.
2016
-
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma..
7:47794-47807.
2016
-
Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer..
7:47620-47636.
2016
-
Racial differences in prostate inflammation: results from the REDUCE study.
2016
-
Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer..
7:42385-42392.
2016
-
Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis..
7:38845-38856.
2016
-
A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer..
7:34472-34479.
2016
-
FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms..
7:34371-34383.
2016
-
Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy..
7:35015-35025.
2016
-
Unexpected positive control of NFκB and miR-155 by DGKα and ζ ensures effector and memory CD8+ T cell differentiation..
7:33744-33764.
2016
-
Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population..
7:28112-28123.
2016
-
PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reaction.
7:28218-28234.
2016
-
Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer..
7:25291-25303.
2016
-
Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx..
7:26444-26453.
2016
-
Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer..
7:24088-24096.
2016
-
High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid..
7:21631-21643.
2016
-
Key roles of necroptotic factors in promoting tumor growth..
7:22219-22233.
2016
-
MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer..
7:20381-20394.
2016
-
Safety of two-year caloric restriction in non-obese healthy individuals..
7:19124-19133.
2016
-
The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer..
7:20293-20304.
2016
-
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker..
7:18036-18049.
2016
-
Genetic variant rs4072037 of MUC1 and gastric cancer risk in an Eastern Chinese population..
7:15930-15936.
2016
-
Serum protein profiling using an aptamer array predicts clinical outcomes of stage IIA colon cancer: A leave-one-out crossvalidation..
7:16338-16348.
2016
-
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer..
7:13587-13598.
2016
-
Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia..
7:14659-14672.
2016
-
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition..
7:12386-12392.
2016
-
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty..
7:11899-11912.
2016
-
PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population..
7:9420-9428.
2016
-
A targeted genetic association study of epithelial ovarian cancer susceptibility..
7:7381-7389.
2016
-
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer..
7:6353-6368.
2016
-
Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)..
7:6984-6993.
2016
-
Angiomirs expression profiling in diffuse large B-Cell lymphoma..
7:4806-4816.
2016
-
The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia..
7:2721-2733.
2016
-
Endosome and INPP4B..
7:5-6.
2016
-
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma..
7:2401-2416.
2016
-
Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese population..
6:42661-42666.
2015
-
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk..
6:42468-42477.
2015
-
Prevalence of deleterious ATM germline mutations in gastric cancer patients..
6:40953-40958.
2015
-
The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion..
6:41350-41359.
2015
-
Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma..
6:40283-40294.
2015
-
MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management..
6:38591-38616.
2015
-
microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu)..
6:38705-38718.
2015
-
Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens..
6:38372-38380.
2015
-
A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer..
6:34745-34757.
2015
-
LGR5 is associated with tumor aggressiveness in papillary thyroid cancer..
6:34549-34560.
2015
-
Caspase 3 in dying tumor cells mediates post-irradiation angiogenesis..
6:32353-32367.
2015
-
IL-11 in multiple sclerosis..
6:32297-32298.
2015
-
Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration..
6:33769-33780.
2015
-
The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis..
6:33358-33368.
2015
-
Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin..
6:25061-25073.
2015
-
TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas..
6:24871-24883.
2015
-
Hyperinflammation, T cells, and endotoxemia..
6:23040-23041.
2015
-
Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells..
6:23959-23986.
2015
-
Perifosine as a potential novel anti-telomerase therapy..
6:21816-21826.
2015
-
Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma..
6:23157-23180.
2015
-
BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine..
6:19445-19455.
2015
-
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival..
6:18653-18663.
2015
-
MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma..
6:18374-18388.
2015
-
Dynamic treatment effect (DTE) curves reveal the mode of action for standard and experimental cancer therapies..
6:14656-14668.
2015
-
Erratum: Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries..
6:14720.
2015
-
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?.
6:13933-13945.
2015
-
Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone..
6:11357-11368.
2015
-
TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome..
6:7727-7740.
2015
-
Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries..
6:5615-5633.
2015
-
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma..
6:5597-5614.
2015
-
Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth..
6:4266-4273.
2015
-
Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A..
6:2164-2179.
2015
-
Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple staining.
6:20278-20287.
2015
-
A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly..
5:11813-11826.
2014
-
A recessive variant of XRCC4 predisposes to non- BRCA1/2 breast cancer in chinese women and impairs the DNA damage response via dysregulated nuclear localization..
5:12218-12232.
2014
-
The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors..
5:9033-9038.
2014
-
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors..
5:8161-8172.
2014
-
The NF1 gene revisited - from bench to bedside..
5:5873-5892.
2014
-
Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance..
5:3770-3784.
2014
-
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma..
5:2635-2647.
2014
-
Caspase-8-mediated PAR-4 cleavage is required for TNFα-induced apoptosis..
5:2988-2998.
2014
-
Molecular pathways and therapeutic targets in lung cancer..
5:1392-1433.
2014
-
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas..
5:1515-1525.
2014
-
The genetic landscape of anaplastic astrocytoma..
5:1452-1457.
2014
-
Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer..
5:1062-1070.
2014
-
KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation..
4:2144-2153.
2013
-
Exomic sequencing of four rare central nervous system tumor types..
4:572-583.
2013
-
Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans..
3:1428-1438.
2012
-
Mutant IDH1 is required for IDH1 mutated tumor cell growth..
3:774-782.
2012
-
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas..
3:709-722.
2012
-
Double agents in the war on cancer: leukocytes govern ovarian cancer progression..
3:226-227.
2012
-
Toll-like receptor 2: Therapeutic target for gastric carcinogenesis.
3:1260-1261.
2012
-
CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells..
1:329-338.
2010
-
Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes..
1:265-277.
2010